Scott, Kayla M.
Cohen, D. Joshua
Nielson, Dane W.
Kim, Gloria
Olson, Lucas C.
McClure, Michael J.
Grinstaff, Mark W.
Boyan, Barbara D.
Schwartz, Zvi
Funding for this research was provided by:
Alice T. and William H. Goodwin Jr. Chair
Article History
Received: 20 February 2022
Accepted: 13 September 2022
First Online: 27 September 2022
Competing interests
: Kayla M. Scott, D. Joshua Cohen, Barbara D. Boyan and Zvi Schwartz have a patent application (SCH-20–161) on the use of microRNA inhibition to prevent and treat traumatic osteoarthritis and other inflammatory diseases. The other authors declare no competing interests.